getting paid seems to be an issue for them. When investors look at the medical space generally, this isn’t something they see as a risk. So this is a big negative associated with the countries they operate in.
discounted rights issue coming to force existing holders to dip into their wallets. I agree with Wilbur’s comments above, no point selling even if you could get out
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
0.050(17.9%) |
Mkt cap ! $17.70M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 33.0¢ | 33.0¢ | $1.13K | 3.424K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 12338 | 1 |
View Market Depth
| Last trade - 15.22pm 30/07/2025 (20 minute delay) ? |
| IME (ASX) Chart |